Imaging mass spectrometry distinguished the cancer and stromal regions of oral squamous cell carcinoma by visualizing phosphatidylcholine (16:0/16:1) and phosphatidylcholine (18:1/20:4).
about
Advances in Lipidomics for Cancer Biomarkers DiscoveryIncreased phosphatidylcholine (16:0/16:0) in the folliculus lymphaticus of Warthin tumorSpatial segmentation of MALDI FT-ICR MSI data: a powerful tool to explore the head and neck tumor in situ lipidome.Decreased level of phosphatidylcholine (16:0/20:4) in multiple myeloma cells compared to plasma cells: a single-cell MALDI-IMS approach.MALDI mass spectrometric imaging meets "omics": recent advances in the fruitful marriage.Direct profiling of the phospholipid composition of adult Caenorhabditis elegans using whole-body imaging mass spectrometry.Novel workflow for combining Raman spectroscopy and MALDI-MSI for tissue based studies.Phospholipids as cancer biomarkers: Mass spectrometry-based analysis.Plasma lipid profiling and diagnostic biomarkers for oral squamous cell carcinoma.
P2860
Q28079507-EE06B68B-A726-4F16-8E7C-5EC725A400BAQ34144828-879BCBD8-8B12-404A-8100-57293AC6C4CCQ35397930-16E6E82C-8184-47D1-8397-3460662D8C27Q35626025-4DFCB8D9-07D9-4020-A391-F8640DEBB48CQ35687880-CB827516-9C3D-4A43-974E-E9FEE0C7CAC3Q35756667-59FE96B2-6A47-44BC-BDB6-FBCF215E880FQ35776848-949B96A5-33D9-4B9B-9476-D6E11FE5F3FAQ36045221-3796B876-7CE0-4BA1-A53B-7200B33F794CQ47148343-53D2F66C-AFED-4302-8C64-E35D3322E53D
P2860
Imaging mass spectrometry distinguished the cancer and stromal regions of oral squamous cell carcinoma by visualizing phosphatidylcholine (16:0/16:1) and phosphatidylcholine (18:1/20:4).
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Imaging mass spectrometry dist ...... osphatidylcholine (18:1/20:4).
@ast
Imaging mass spectrometry dist ...... osphatidylcholine (18:1/20:4).
@en
Imaging mass spectrometry dist ...... isualizing phosphatidylcholine
@nl
type
label
Imaging mass spectrometry dist ...... osphatidylcholine (18:1/20:4).
@ast
Imaging mass spectrometry dist ...... osphatidylcholine (18:1/20:4).
@en
Imaging mass spectrometry dist ...... isualizing phosphatidylcholine
@nl
prefLabel
Imaging mass spectrometry dist ...... osphatidylcholine (18:1/20:4).
@ast
Imaging mass spectrometry dist ...... osphatidylcholine (18:1/20:4).
@en
Imaging mass spectrometry dist ...... isualizing phosphatidylcholine
@nl
P2093
P2860
P1476
Imaging mass spectrometry dist ...... osphatidylcholine (18:1/20:4).
@en
P2093
Fuminori Katou
Kazuma Masumoto
Mitsutoshi Setou
Noritaka Masaki
Takahiro Hayasaka
Tetsuji Nagata
Yoshiko Watanabe
Yoshiyuki Uchiyama
P2860
P2888
P304
P356
10.1007/S00216-013-7062-3
P407
P577
2013-06-01T00:00:00Z